Shu Zheng

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Venues

Cell discovery

Cancer management and research

OncoTargets and therapy

Oncoimmunology

This page only lists publications with an associated author ORCID identifier.

Publications

Kailun Xu, Xiaoyang Yin, Hui Chen, Yuhui Huang, Xi Zheng, Biting Zhou, Xue Cai, Huanhuan Gao, Miaomiao Tian, Sijun Hu, Shu Zheng, Changzheng Yuan, Yongzhan Nie, Tiannan Guo, Yingkuan Shao
Prediction of overall survival in stage II and III colon cancer through machine learning of rapidly-acquired proteomics. Cell discovery 10 (1) (2024)
Kailun Xu, Xiaoyang Yin, Hui Chen, Yuhui Huang, Xi Zheng, Biting Zhou, Xue Cai, Huanhuan Gao, Miaomiao Tian, Sijun Hu, Shu Zheng, Changzheng Yuan, Yongzhan Nie, Tiannan Guo, Yingkuan Shao
Prediction of overall survival in stage II and III colon cancer through machine learning of rapidly-acquired proteomics. Cell discovery 10 (1) (2024)
Kailun Xu, Xiaoyang Yin, Hui Chen, Yuhui Huang, Xi Zheng, Biting Zhou, Xue Cai, Huanhuan Gao, Miaomiao Tian, Sijun Hu, Shu Zheng, Changzheng Yuan, Yongzhan Nie, Tiannan Guo, Yingkuan Shao
Prediction of overall survival in stage II and III colon cancer through machine learning of rapidly-acquired proteomics. Cell discovery 10 (1) (2024)
Yaoting Sun, Sathiyamoorthy Selvarajan, Zelin Zang, Wei Liu, Yi Zhu, Hao Zhang, Wanyuan Chen, Hao Chen, Lu Li, Xue Cai, Huanhuan Gao, Zhicheng Wu, Yongfu Zhao, Lirong Chen, Xiaodong Teng, Sangeeta Mantoo, Tony Kiat-Hon Lim, Bhuvaneswari Hariraman, Serene Yeow, Syed Muhammad Fahmy Alkaff, Sze Sing Lee, Guan Ruan, Qiushi Zhang, Tiansheng Zhu, Yifan Hu, Zhen Dong, Weigang Ge, Qi Xiao, Weibin Wang, Guangzhi Wang, Junhong Xiao, Yi He, Zhihong Wang, Wei Sun, Yuan Qin, Jiang Zhu, Xu Zheng, Linyan Wang, Xi Zheng, Kailun Xu, Yingkuan Shao, Shu Zheng, Kexin Liu, Ruedi Aebersold, Haixia Guan, Xiaohong Wu, Dingcun Luo, Wen Tian, Stan Ziqing Li, Oi Lian Kon, Narayanan Gopalakrishna Iyer, Tiannan Guo
Artificial intelligence defines protein-based classification of thyroid nodules. Cell discovery 8 (1) (2022)
Yaoting Sun, Sathiyamoorthy Selvarajan, Zelin Zang, Wei Liu, Yi Zhu, Hao Zhang, Wanyuan Chen, Hao Chen, Lu Li, Xue Cai, Huanhuan Gao, Zhicheng Wu, Yongfu Zhao, Lirong Chen, Xiaodong Teng, Sangeeta Mantoo, Tony Kiat-Hon Lim, Bhuvaneswari Hariraman, Serene Yeow, Syed Muhammad Fahmy Alkaff, Sze Sing Lee, Guan Ruan, Qiushi Zhang, Tiansheng Zhu, Yifan Hu, Zhen Dong, Weigang Ge, Qi Xiao, Weibin Wang, Guangzhi Wang, Junhong Xiao, Yi He, Zhihong Wang, Wei Sun, Yuan Qin, Jiang Zhu, Xu Zheng, Linyan Wang, Xi Zheng, Kailun Xu, Yingkuan Shao, Shu Zheng, Kexin Liu, Ruedi Aebersold, Haixia Guan, Xiaohong Wu, Dingcun Luo, Wen Tian, Stan Ziqing Li, Oi Lian Kon, Narayanan Gopalakrishna Iyer, Tiannan Guo
Author Correction: Artificial intelligence defines protein-based classification of thyroid nodules. Cell discovery 8 (1) (2022)
Kailai Wang, Yanmei Yang, Shu Zheng, Wangxiong Hu
Association Mining Identifies MAL2 as a Novel Tumor Suppressor in Colorectal Cancer. OncoTargets and therapy 15 (2022)
Yingkuan Shao, Kailun Xu, Xi Zheng, Biting Zhou, Xiuli Zhang, Lin Wang, Yaoting Sun, Dan Li, Ting Chen, Jian Wang, Shaojun Yu, Lifeng Sun, Xiaoming Xu, Shaozhi Dai, Huanhuan Gao, Guan Ruan, Wei Liu, Xue Cai, Tiansheng Zhu, Lina Qi, Jiani Chen, Wangxiong Hu, Xingyue Weng, Yi Zhu, Xueping Xiang, Zhiyuan Hu, Jinfan Li, Lirong Chen, Jimin Shao, Shu Zheng, Tiannan Guo
Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target. Cancer communications (London, England) (2021)
Jiaojiao Zhou, Xuan Zhu, Shijie Wu, Jingxin Guo, Kun Zhang, Chunjing Xu, Huihui Chen, Yuxi Jin, Yuting Sun, Shu Zheng, Yi-Ding Chen
Epithelial-mesenchymal transition status of circulating tumor cells in breast cancer and its clinical relevance. Cancer biology & medicine 17 (1) (2021)
Lina Qi, Jiani Chen, Biting Zhou, Kailun Xu, Kailai Wang, Zhihao Fang, Yingkuan Shao, Ying Yuan, Shu Zheng, Wangxiong Hu
HomeoboxC6 promotes metastasis by orchestrating the DKK1/Wnt/β-catenin axis in right-sided colon cancer. Cell death & disease 12 (4) (2021)
Yamei Zhao, Chao Chen, Xiaoming Xu, Xiaoxu Ge, Kefeng Ding, Shu Zheng, Jian Wang, Lifeng Sun
An Efficient Prognostic Immune Scoring System For Colorectal Cancer Patients With Peritoneal Metastasis. Oncoimmunology 10 (1) (2021)
Biting Zhou, Kailun Xu, Xi Zheng, Ting Chen, Jian Wang, Yongmao Song, Yingkuan Shao, Shu Zheng
Application of exosomes as liquid biopsy in clinical diagnosis. Signal transduction and targeted therapy 5 (1) (2020)
Xi Zheng, Kailun Xu, Biting Zhou, Ting Chen, Yanqin Huang, Qilong Li, Fei Wen, Weiting Ge, Jian Wang, Shaojun Yu, Lifeng Sun, Liang Zhu, Wei Liu, Huanhuan Gao, Liang Yue, Xue Cai, Qiushi Zhang, Guan Ruan, Tiansheng Zhu, Zhicheng Wu, Yi Zhu, Yingkuan Shao, Tiannan Guo, Shu Zheng
A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry. Journal of extracellular vesicles 9 (1) (2020)
Chao Chen, Jian Wang, Yamei Zhao, Xiaoxu Ge, Zhanhuai Wang, Shaojun Yu, Yongmao Song, Kefeng Ding, Suzhan Zhang, Shu Zheng, Lifeng Sun
Factors Prognostic for Peritoneal Metastases from Colorectal Cancer Treated with Surgery. Cancer management and research 12 (2020)
Shan-Rong Cai, Yan-Qin Huang, Su-Zhan Zhang, Qi-Rong Li, Xin Yuan Ma, Shu Zheng
Effects of subitems in the colorectal cancer screening protocol on the Chinese colorectal cancer screening program: an analysis based on natural community screening results. BMC cancer 19 (1) (2019)

Shu Zheng.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shu Zheng